Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study

DSpace Repository

Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study

Author: Martin, Thomas G.; Moreau, Philippe; Usmani, Saad Z.; Garfall, Alfred; Mateos, Maria -Victoria; San-Miguel, Jesus F.; Oriol, Albert; Nooka, Ajay K.; Rosinol, Laura; Chari, Ajai; Karlin, Lionel; Krishnan, Amrita; Bahlis, Nizar; Popat, Rakesh; Besemer, Britta; Martinez-Lopez, Joaquin; Delforge, Michel; Trancucci, Danielle; Pei, Lixia; Kobos, Rachel; Fastenau, John; Gries, Katharine S.; van de Donk, Niels W. C. J.
Tübinger Autor(en):
Besemer, Britta
Published in: Clinical Lymphoma Myeloma & Leukemia (2024), Bd. 24, H. 3, S. 194-202
Verlagsangabe: Dallas : Cig Media Group, Lp
Language: English
Full text: http://dx.doi.org/10.1016/j.clml.2023.11.001
ISSN: 2152-2650
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)